Alaunos Therapeutics (TCRT) Asset Utilization Ratio (2011 - 2026)
Alaunos Therapeutics' (TCRT) quarterly Asset Utilization Ratio came in at 0.0 in Q1 2026, down 69.84% YoY from 0.0 in Q1 2025, and down 17.22% on a QoQ basis from 0.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 14 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 69.84% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 69.84% YoY) and the FY2025 annual result came in at 0.0, down 3.71% from the prior year.
- Asset Utilization Ratio slipped to 0.0 in Q1 2026, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.08 in Q2 2023 to a low of 0.0 in Q3 2023.
- A 5-year average of 0.01 and a median of 0.0 in 2025 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 1406.92% in 2023, down 100.72% in 2023.
- Tracing TCRT's Asset Utilization Ratio over 5 years: stood at 0.04 in 2022, then tumbled by 99.18% to 0.0 in 2023, then soared by 690.89% to 0.0 in 2024, then slumped by 47.64% to 0.0 in 2025, then declined by 17.22% to 0.0 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Dec 31, 2018 | 0.00 |